Wire · opportunities
ARPA-H taps 7 organizations for AI cardiovascular care platform
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 21 September 2026 · Fusion42 review
ARPA-H has allocated up to $33.7 million in the first year of a four-year $62.7 million program called ADVOCATE to develop AI-driven clinical and patient engagement tools for cardiovascular care, aiming to overcome geographic barriers and improve outcomes. The program involves seven organizations including tech companies and academic institutions collaborating to create, implement, and validate autonomous AI agents in cardiology, with a focus on regulatory frameworks and rural accessibility.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
Autonomous AI in cardiovascular care is moving from concept to large-scale clinical testing with clear regulatory pathways forming, signalling a new market opening for patient-facing AI tools. You can position your digital health venture now to collaborate with or supply scalable AI engagement and supervisory systems ahead of FDA approvals.
◆ Coverage
1 source · 21 Sep 2026
◆ Related on Wire
◆ Topics